Qiagen N.V.
QGEN
Ранг среди акций
#2133
Qiagen N.V. provides sample to insight solutions that transform biological... Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
Цена акции
$46.54
Последняя синхронизация: 2026-10-19
Рыночная капитализация
$9.59B
Изменение (1 день)
0.79%
Изменение (1 год)
-4.39%
Страна
NL
Торговля Qiagen N.V. (QGEN)
Категория
Healthcare
EPS для Qiagen N.V. (QGEN)
EPS по состоянию на June 2026 TTM: $1.95
Согласно последним финансовым отчетам и цене акций Qiagen N.V., текущий EPS компании (TTM) составляет $1.95. В конце 2024 EPS компании составлял $0.39, меньше, чем показателю 2023 года, равному $1.67.
История EPS компании Qiagen N.V. с 2000 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| 2026 (TTM) | $1.95 | -4.41% |
| 2025 | $2.04 | 423.08% |
| 2024 | $0.39 | -76.65% |
| 2023 | $1.67 | -19.71% |
| 2022 | $2.08 | -17.46% |
| 2021 | $2.52 | 663.64% |
| 2020 | $0.33 | -273.68% |
| 2019 | $-0.19 | -122.62% |
| 2018 | $0.84 | 366.67% |
| 2017 | $0.18 | -50.00% |
| 2016 | $0.36 | -36.84% |
| 2015 | $0.57 | 9.62% |
| 2014 | $0.52 | 67.74% |
| 2013 | $0.31 | -45.61% |
| 2012 | $0.57 | 32.56% |
| 2011 | $0.43 | -32.81% |
| 2010 | $0.64 | -8.57% |
| 2009 | $0.70 | 48.94% |
| 2008 | $0.47 | 51.61% |
| 2007 | $0.31 | -36.73% |
| 2006 | $0.49 | 11.36% |
| 2005 | $0.44 | 29.41% |
| 2004 | $0.34 | 13.33% |
| 2003 | $0.30 | 76.47% |
| 2002 | $0.17 | -32.00% |
| 2001 | $0.25 | 56.25% |
| 2000 | $0.16 | 0.00% |
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| $18.62 | 854.87% |
US
|
|
| $5.65 | 189.74% |
US
|
|
| $-1.36 | -169.74% |
US
|
|
| - | - |
CN
|
|
| $5.09 | 161.03% |
US
|
